Pharmaceutics

ISSN	1999-4923
ISSN-L	-
IUID	e06452573d704b81a200f3bd55917914
Modified	2020-11-30T21:39:19.061Z
Created	2020-11-30T21:39:19.061Z

Year 2025

PubMed DOI Crossref

Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer's Disease Targeting.

Turkez H, Oner S, Yıldırım OC, ..., Di Stefano A, Mardinoglu A

Pharmaceutics 17 (2) - [2025-02-17; online 2025-02-17]

Year 2024

PubMed DOI Crossref

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.

Obeid K, Kanellopoulos P, Abouzayed A, ..., Maina T, Orlova A

Pharmaceutics 16 (4) - [2024-04-08; online 2024-04-08]

Year 2023

PubMed DOI Crossref

Challenges in Permeability Assessment for Oral Drug Product Development.

Koziolek M, Augustijns P, Berger C, ..., Weitschies W, Dressman J

Pharmaceutics 15 (10) - [2023-09-28; online 2023-09-28]

PubMed DOI Crossref

Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX®-Design Nanoparticles.

Lerouge L, Gries M, Chateau A, ..., Thomas N, Barberi-Heyob M

Pharmaceutics 15 (3) - [2023-03-20; online 2023-03-20]

PubMed DOI Crossref

[18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44.

Cheung P, Amin MA, Zhang B, ..., Odell LR, Eriksson O

Pharmaceutics 15 (2) - [2023-02-02; online 2023-02-02]

Olof Eriksson SciLifeLab Fellow

Year 2022

PubMed DOI Crossref

Lipoic Acid Conjugated Boron Hybrids Enhance Wound Healing and Antimicrobial Processes.

Türkez H, Yıldırım ÖÇ, Öner S, ..., Yapça ÖE, Mardinoğlu A

Pharmaceutics 15 (1) - [2022-12-31; online 2022-12-31]

Adil Mardinoglu SciLifeLab Fellow

PubMed DOI Crossref

Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis.

Liu Y, Güler R, Liao Y, ..., Tolmachev V, Frejd FY

Pharmaceutics 14 (11) - [2022-11-19; online 2022-11-19]

PubMed DOI Crossref

Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands.

Lundmark F, Olanders G, Rinne SS, ..., Orlova A, Rosenström U

Pharmaceutics 14 (5) - [2022-05-20; online 2022-05-20]

PubMed DOI Crossref

Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria.

Öhnstedt E, Lofton Tomenius H, Frank P, ..., Vågesjö E, Phillipson M

Pharmaceutics 14 (2) - [2022-01-19; online 2022-01-19]

Year 2021

PubMed DOI Crossref

The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy.

Yin W, Xu T, Altai M, ..., Gräslund T, Orlova A

Pharmaceutics 13 (11) - [2021-11-21; online 2021-11-21]

PubMed DOI Crossref

The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles

Hempel NJ, Merkl P, Knopp MM, ..., Sotiriou GA, Löbmann K

Pharmaceutics 13 (6) 917 [2021-06-21; online 2021-06-21]

Alexandra Teleki SciLifeLab Fellow

PubMed DOI Crossref

Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer.

Abouzayed A, Rinne SS, Sabahnoo H, ..., Tolmachev V, Orlova A

Pharmaceutics 13 (2) - [2021-01-30; online 2021-01-30]

Year 2020

PubMed DOI Crossref

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer.

Abouzayed A, Tano H, Nagy Á, ..., Eriksson Karlström A, Orlova A

Pharmaceutics 12 (10) - [2020-10-16; online 2020-10-16]

PubMed DOI Crossref

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model.

Lundmark F, Abouzayed A, Mitran B, ..., Rosenström U, Orlova A

Pharmaceutics 12 (7) - [2020-07-01; online 2020-07-01]

PubMed DOI Crossref

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.

Leitao CD, Rinne SS, Altai M, ..., Ståhl S, Orlova A

Pharmaceutics 12 (6) - [2020-06-13; online 2020-06-13]

PubMed DOI Crossref

Intrinsic Dissolution Rate Profiling of Poorly Water-Soluble Compounds in Biorelevant Dissolution Media.

Teleki A, Nylander O, Bergström CAS

Pharmaceutics 12 (6) 493 [2020-05-28; online 2020-05-28]

Alexandra Teleki SciLifeLab Fellow

Year 2019

PubMed DOI Crossref

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart.

Oroujeni M, Abouzayed A, Lundmark F, ..., Tolmachev V, Rosenström U

Pharmaceutics 11 (8) - [2019-08-02; online 2019-08-02]

PubMed DOI Crossref

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.

Abouzayed A, Yim CB, Mitran B, ..., Rosenström U, Orlova A

Pharmaceutics 11 (7) - [2019-07-23; online 2019-07-23]